96
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review

      1 , 1
      Annals of Internal Medicine
      American College of Physicians

      Read this article at

      ScienceOpenPublisher
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly throughout the world since the first cases of coronavirus disease 2019 (COVID-19) were observed in December 2019 in Wuhan, China. It has been suspected that infected persons who remain asymptomatic play a significant role in the ongoing pandemic, but their relative number and effect have been uncertain. The authors sought to review and synthesize the available evidence on asymptomatic SARS-CoV-2 infection. Asymptomatic persons seem to account for approximately 40% to 45% of SARS-CoV-2 infections, and they can transmit the virus to others for an extended period, perhaps longer than 14 days. Asymptomatic infection may be associated with subclinical lung abnormalities, as detected by computed tomography. Because of the high risk for silent spread by asymptomatic persons, it is imperative that testing programs include those without symptoms. To supplement conventional diagnostic testing, which is constrained by capacity, cost, and its one-off nature, innovative tactics for public health surveillance, such as crowdsourcing digital wearable data and monitoring sewage sludge, might be helpful.

          Related collections

          Author and article information

          Journal
          Annals of Internal Medicine
          Annals of Internal Medicine
          American College of Physicians
          0003-4819
          1539-3704
          June 03 2020
          Affiliations
          [1 ]Scripps Research Translational Institute, Scripps Research, La Jolla, California (D.P.O., E.J.T.)
          Article
          10.7326/M20-3012
          b4c7e22c-4319-409b-b5d5-958d33d8cad7
          © 2020
          History

          Comments

          Comment on this article